IKEUCHI
8.1.2024 13:01:28 CET | Business Wire | Press release
H. IKEUCHI & CO., LTD., a Japanese spray nozzles manufacturer, has launched a global campaign to introduce humidity control systems powered by “Dry Fog” technology.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240108276401/en/
Each individual photo available upon request: IKEUCHI offers humidity control systems using Dry Fog not only preventing static electricity in SMT processes but also significantly slashing operating costs and CO2 emissions.(Photo: Business Wire)
“Dry Fog” is formed out of ultrafine water droplets, each measuring 10 μm or less in diameter, generated by specialized spray nozzles. This fog rapidly evaporates into the air without wetting the objects it touches.
In the realm of surface-mount technology (SMT) processes, effective humidity control is crucial to combat electrostatic discharge (ESD) issues and challenges arising from static electricity and dry air. IKEUCHI's Dry Fog Humidification System emerges as a groundbreaking solution, delivering seven key benefits.
1. ESD Damage Prevention
As electronic components shrink, susceptibility to electrostatic discharge increases. The Dry Fog system ensures a uniform humidity level, preventing the risk of ESD damage.
2. Reduced Pick-and-Place Errors
Maintaining optimal humidity levels minimizes errors in the pick-and-place process caused by components sticking to or popping out from the tape due to static charge, boosting productivity.
3. Consistent Solder Print Quality
Humidity control during solder printing prevents issues like rapid drying or excessive moisture absorption, ensuring consistent solder print quality and product reliability.
4. Airborne Particle Reduction
Humidification curbs airborne particles, reducing defects caused by particle adherence. The Dry Fog system significantly decreases airborne particles with increased humidity.
5. Significant Operating Cost Reduction
Compared to conventional steam humidification, the Dry Fog system slashes operating costs by 68%, resulting in $50,000/year savings and a 70% CO2 emissions reduction.
6. Cooling Cost Reduction
Evaporative cooling of the Dry Fog lowers ambient temperatures, yielding an $18,000/year saving in cooling expenses at an SMT facility.
7. Healthier Work Environment
Beyond manufacturing, the Dry Fog system reduces sick leave by maintaining a relative humidity of 50% or above, leading to fewer sick days during winter.
In conclusion, IKEUCHI's Dry Fog Humidification System is a comprehensive solution addressing crucial aspects of SMT processes, enhancing productivity, reducing costs, and fostering a healthier workplace. This technology offers a transformative approach to humidity control in electronics manufacturing.
Links to Articles: Part 1, Part 2, Part. 3
Network: U.S., Europe, China, Taiwan, Indonesia, Thailand, Japan
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240108276401/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva26.9.2026 01:00:00 CEST | Press release
-Once-daily oral ALK2 inhibitor approved to reduce the volume of total new heterotopic ossification in patients aged 12 years and older with FOP-Atebrioz expected to be available in the United States in October through Mirum Access Plus (MAP), with eligible patients paying as little as $0 per month-PROGRESS pediatric development program continues to evaluate zilurgisertib in children aged 2 to <12 years Mirum Pharmaceuticals, Inc. (Nasdaq:MIRM) and Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Atebrioz™ (zilurgisertib) tablets to reduce the volume of total new heterotopic ossification (HO) in adult and pediatric patients aged 12 years and older with fibrodysplasia ossificans progressiva (FOP). The recommended dose of Atebrioz is 100 mg administered orally, once daily. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260925436454/en/ “Today marks an important milestone for pe
Digital Reef Signs Offtake Agreement with Oreasoc Agriculture to Mitigate the Environmental Footprint of Data Centre Growth Through Rainforest Protection, Appointing Xange.com as Digital MRV Partner25.9.2026 21:19:00 CEST | Press release
The offtake agreement connects Digital Reef’s 3.3 GW data centre pipeline with environmental assets from more than 30 million hectares of Amazon rainforest across South America, where Oreasoc Agriculture works directly on the ground alongside local communities to develop sustainable economies and safeguard their territories. Xange.com’s digital MRV technology monitors both the data centres and the rainforest. At Climate Week NYC, Digital Reef and Oreasoc Agriculture Inc. sign an offtake agreement connecting Digital Reef’s 3.3 GW data centre pipeline with environmental assets exceeding 30 million hectares of South American Amazon rainforest, mitigating the environmental footprint of data centre growth through rainforest protection and restoration where Oreasoc works alongside local communities to protect biodiversity, develop sustainable economies and safeguard their territories. Xange.com are appointed as digital MRV technology partner to monitor the data centres and rainforest where D
NetApp Announces Intent to Acquire PEAK:AIO to Advance Scalable AI Infrastructure Architecture25.9.2026 15:00:00 CEST | Press release
Planned acquisition strengthens NetApp's position in the rapidly growing AI infrastructure market by bringing differentiated metadata innovation and parallel file architecture designed for AI NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced its intent to acquire PEAK:AIO, a pioneer in next-generation metadata architecture and high-performance parallel file systems. The planned acquisition is expected to accelerate NetApp's AI infrastructure roadmap by augmenting metadata services and parallel namespace innovation designed to help AI clouds scale shared storage alongside growing GPU clusters. As AI becomes embedded in every enterprise workload, organizations are confronting a new challenge: traditional storage architectures were not designed for the unprecedented scale, concurrency, and performance requirements of AI factories, AI clouds, and next-generation data-intensive applications. NetApp is building an architecture that disaggregates metadata fr
MultiBank Group Secures Two Awards at Forex Expo Dubai 202625.9.2026 14:57:00 CEST | Press release
The Group was recognised for the strength of its global institutional ecosystem and its contribution to financial markets innovation and community impact MultiBank Group, one of the world’s largest financial derivatives institutions, received two awards during its participation at Forex Expo Dubai 2026, held on 22 and 23 September at Dubai World Trade Centre. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260925539591/en/ MultiBank Group was named “Best Global Institutional Financial Ecosystem of the Year” and received the award for “Excellence in Global Financial Markets Innovation and Community Impact.” The Group was named “Best Global Institutional Financial Ecosystem of the Year” and received the award for “Excellence in Global Financial Markets Innovation and Community Impact.” The first award recognised the strength and breadth of MultiBank Group’s global institutional offering, which brings together trading, liquidity
Croma-Pharma Introduces saypha® volume prime Lidocaine25.9.2026 14:04:00 CEST | Press release
New cross-linked hyaluronic acid filler replaces saypha® volume Lidocaine, offering physicians a more versatile solution for both midface volumization and nasolabial folds Croma-Pharma introduces saypha® volume prime Lidocaine, a cross-linked hyaluronic acid dermal filler that replaces saypha® volume Lidocaine within the company's saypha® portfolio. The new product offers physicians a more versatile solution with expanded indications for both midface volumization and nasolabial folds, backed by strong clinical data. 1,2 saypha® volume prime Lidocaine demonstrated non-inferiority to comparatora in a randomized, subject- and evaluator-blinded, controlled, non-inferiority multicenter, parallel group comparison study with almost 500 patients.2 In the clinical evaluation, a high patient satisfaction highlights improved midface fullness, smoothness and contour, consistent with a rheologic profile designed to provide volumization in the mobile midface.b,2 With saypha® volume prime Lidocaine,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
